To explore the role of Fc functions in its anti-tumor effects, we generated a pair of anti-TIGIT antibodies with the same variable regions, but with different Fc forms: BGB-A1217 (with wild-type IgG1 Fc), and BGB-A1217MF (with an Fc lacking FcγR binding capacities). The gene discussed is TIGIT; the disease is neoplasm.